MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1. (Q40965909)
Jump to navigation
Jump to search
scientific article published on March 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1. |
scientific article published on March 1999 |
Statements
1 reference
MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1. (English)
1 reference
Sood R
1 reference
Talwar-Trikha A
1 reference
Chakrabarti SR
1 reference
Nucifora G
1 reference
1 March 1999
1 reference
Identifiers
1 reference